RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 10:58 AM
Followers: 439
Posts Today: 6
Views Today: 74580

CYDY Stock Quote & Tools

$0.2100 ▲ +0.0046 (+2.25%) As of Oct 16, 11:02 AM EDT
Last0.2100
$ Chg0.0046
Open0.2050
High0.2190
Beta1.4964
Year High0.397
Market Cap308.60M
P/B Ratio-2.68
EPS-0.04
Avg Vol (30d)1.57M
Volume1.55M
% Chg+2.25%
Prev Close0.2054
Low0.2050
VWAP0.21102
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. onestepahead

    Could go either way they coulda waited 24-48 hours after last person injected because lawyers need

  2. brentie

    Are you sure about that? I'm still seeing December 15th as the day they completed enrollment.

  3. ohm20

    The data is not being sent to Amarex piecemeal. The only one at Amarex that has had access to data

  4. otcaddict

    There may also be a gap between enrollment and the first shot. Paper work has to be finished first

  5. CDiddy

    Timeframes. I've been stating, rather confidently, that the data will take some time to receive,

    (1)
  6. CDiddy

    I feel you Ken. This has been extraordinarily difficult to watch. Its compounded by my COD

    (16)
  7. KenChowder

    The mortality rate guessing game brings on a couple kinds of cognitive dissonance. On the one

    (16)
  8. CDiddy

    I just re read the PR. The trial completed enrollment of patient 394 on Dec 16, so tomorrow is day

  9. Borel Fields

    Appears pretty linear - one more death in control allows 3 more total deaths to maintain

    (5)
  10. DaveV-1

    Today should be Day 28 or close to it for CD12, enrollment completed Dec 15! Hopefully the

    (3)
  11. ClosetInvestor

    Ill admit that I added more today. These bounces are predictable, especially before the run into

    (4)
  12. Enjay

    With regard to mortality rate, Seth posted the message below on YMB. The point is that mortality

    (9)
  13. mountaineer

    Same here brother! Buying 100 shares earlier is good for me but GLTA

    (1)
  14. Trimble

    And 635,414 shares printed at 16:03:54, 4 trades, 3 x 200K and then 35,414 shares. T-trades after

  15. MarcS

    I thought I had a good chunk of shares, but you old timers (pre-Covid-19) blow mine away. For

  16. mtruong34

    I can agree in terms of dosing, RO would be in the domain of P4. As an efficacy predictor, RO would

  17. mountaineer

    Yea that was crazy again

    (1)
  18. Trimble

    Crazy trading day, within 2 minutes the price plunged from $4.93 to $4.60 about 5 minutes before

    (2)
  19. JLang

    That (RO) is the domain of a follow up / P4... Sure, higher dose and maybe 3 shots would be more

    (1)
  20. cardamine

    Drs. NP and SK got back to me with helpful information as to how to help our family friend get LL

    (22)
  21. HCIT

    You are right on with that ER, Leronlimab can't mitigate that disease of buying more, hee hee.

    (1)
  22. LaundryMoney

    Pretty exciting final 20 minutes of trading if you're into the whole roller coaster thing.

  23. StinkyPennies

    Same, Rabbit. It's like an addiction. 1000 more shares today when I saw that sweet dip.

  24. Evil Rabbit

    I was going to stop adding at 50k, then 60k, 70k, 75k... etc. It's the one disease Leronlimab

    (6)
  25. mtruong34

    But now you have to add back in the number of deaths that still need to be counted because the

  26. HCIT

    ER, I have always remembered you saying that and I get a laugh every time you say just that, "

    (1)
  27. HCIT

    L2L, glad you here and invested in CYDY. Whether you are a long term holder or recently invested

  28. smlf

    you can model in both directions There is an order of magnitude (or two orders of

  29. onestepahead

    I dont think it will be a wash either way. Mainly because of the DSMC recommendation to look at

  30. djaparks

    Thanks for that MarcS. Lol

  31. smlf

    That's exactly my point in arguing that we probably will not have more than 87 deaths within the 28

  32. smlf

    I don't see any relevance either way, You should, since some of the deaths

    (1)
  33. mtruong34

    I'm thinking in the end it will end up as a wash for the final count.

  34. smlf

    deaths outside of the trial are reported until the trial is closed See my point

    (1)
  35. mtruong34

    I would like to add: d) DSMC at 50% interim review asked for 42 days at 75% review. They must

    (3)
  36. Borel Fields

    At least these unknowns (deaths added in final week, deaths to be excluded as >28 days) pull in

    (1)
  37. calstang

    Wait??? Nader said 87 deaths as of the Conference Call last week. Today is the 28 days, so

  38. CDiddy

    Have you seen this printed somewhere? That deaths outside of the trial are reported until the

  39. smlf

    I dont think we know that any of the 87 was outside of 28 days. a) We do know

  40. CDiddy

    Thats sort of what I had in mind. Obviously we dont know which group the fatalities would be

    (3)
  41. CDiddy

    I dont think we know that any of the 87 was outside of 28 days. Its certainly possible, but I

  42. Borel Fields

    Unfortunately, you can model in both directions: 1) If you think you know the death rate in the

    (2)
  43. Beasley

    I put in a small order at $4.70 which filled...of course it drops lower after mine filled. Oh well,

  44. MarcS

    We bounce on $4.25. Isn't 2020 hindsight wonderful? After being away from the computer, I started

    (3)
  45. Bw

    While some agree or disagree .... I wouldn't mind seeing PR saying last patient hit 28th day ... At

    (2)
  46. LateToLearn

    Hold on there HCIT... As my handle suggests, I was late finding CYDY but still am buying all

  47. reallypeople?

    Was it pretty much silence that took us up to 6-7 in anticipation of an event ?

    (1)
  48. Bw

    Ya a lot of ppl are tapped out .... Some fresh investors wouldn't hurt ..... Perhaps time to line

    (1)
  49. Evil Rabbit

    I added a few hundred, but its true that most longs are maxed out. Swore I wouldnt buy more

    (1)
  50. smlf

    It is worth noting that 87 deaths announced so far include deaths outside of the 28 day period and

    (2)

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

Modine Manufacturing Soars: A Bright Future Ahead for MOD

Updated Category News Views 179

Modine Manufacturing's Stock Hits New Highs Modine Manufacturing Company's stock has soared to a record high, reaching an impressive price of $123.95. This milestone marks a remarkable increase of 176.54%, demonstrating a strong boost in market confidence and underscoring the company's excellent performance over the past year. Much of this positive sentiment stems from...

Continue Reading
Corvex Q2 Earnings Call Set: AI Strategy in Focus

Updated Category News Views 20

Corvex's Q2 Earnings Call: Why It Matters Investors, clear your calendars for August 14, 2026, because Corvex, Inc. is about to offer some insights into the cogs and gears of their operations. Mark 4:30 p.m. ET for a peek into how their AI strategies are expected to reshape the market. They're a player in the AI infrastructure game, and when you've got a dog in that race,...

Continue Reading
FTAI Aviation Ltd Faces Securities Fraud Class Action Lawsuit

Updated Category News Views 179

FTAI Aviation Ltd. Under Legal Scrutiny The law firm Kessler Topaz Meltzer & Check, LLP has recently made an important announcement regarding FTAI Aviation Ltd. (NASDAQ: FTAI). Investors of FTAI should pay attention to the developments surrounding a securities fraud class action lawsuit that has emerged in the United States District Court for the Southern District of New...

Continue Reading
Cronos Group's Annual Meeting: Shareholder Engagement Insights

Updated Category News Views 196

Shareholder Participation in Cronos Group's Annual Meeting On a recent date, the Annual Meeting of Shareholders for Cronos Group Inc. (NASDAQ: CRON) occurred, marking a significant moment for the company. The engagement observed during this meeting, with a remarkable 71.87% of shareholders voting, underscores the commitment of stakeholders to influence corporate...

Continue Reading
Palantir Technologies Predicts Growth in Upcoming Earnings Release

Updated Category News Views 215

Palantir Technologies Expectations for Q3 Earnings Palantir Technologies Inc. (NASDAQ: PLTR) is on the verge of announcing its earnings results for the third quarter. Anticipation is building as investors prepare for the release, which is expected to unveil significant growth compared to previous periods. Financial Predictions and Revenue Expectations Analysts are...

Continue Reading